Maricann Group (CNSX:MARI) Given New $14.00 Price Target at National Bank Financial

Maricann Group (CNSX:MARIFree Report) had its target price cut by National Bank Financial from $15.00 to $14.00 in a research report sent to investors on Wednesday morning,BayStreet.CA reports. They currently have an outperform rating on the stock.

Maricann Group Stock Performance

Maricann Group has a 12 month low of $0.87 and a 12 month high of $3.60.

About Maricann Group

(Get Free Report)

Maricann Group Inc, formerly Danbel Industries Corporation, is a Canada-based integrated producer and distributor of marijuana for medical purposes. As one of approximately 43 companies with a federal license to cultivate cannabis and one of approximately 30 independent licensed producers with a federal license to process and distribute cannabis, the Company’s services a patient base with more than 8,000 registered patients. The Company is undertaking an expansion of the cultivation and support facilities to support existing and future patient growth.

Featured Stories

Receive News & Ratings for Maricann Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maricann Group and related companies with MarketBeat.com's FREE daily email newsletter.